This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Partners In Health, Abbott And The Abbott Fund Open Nutrition Facility In Haiti

CORPORANT, Haiti, Nov. 6, 2013 /PRNewswire/ -- Partners In Health (PIH), Abbott and its foundation, the Abbott Fund, today announced the opening of a new nutrition production facility in the Central Plateau in Haiti. The centerpiece of a broader partnership between PIH, Abbott and the Abbott Fund to help drive economic development in the region, the facility will produce "Nourimanba," a life-saving treatment for severe malnutrition in children. The first shipments of Nourimanba produced at the new facility have been distributed to PIH's clinics in the region, and are already being used to provide effective treatment for children.

(Photo: http://photos.prnewswire.com/prnh/20131106/AQ11194) "After several years of close collaboration, we are excited to achieve this significant milestone in our partnership with Abbott and the Abbott Fund. Producing Nourimanba at the new facility will help PIH and Zanmi Lasante to continue providing free, high-quality treatment for children at our clinics across the region," said Ophelia Dahl, PIH co-founder and executive director. "The impact of this partnership goes well beyond a building. As an employer and a customer for local farmers, this facility aims to spark a cluster of economic activity that is desperately needed in the region."

A New Facility, With a Broader ImpactThe 18,000 square-foot Nourimanba Production Facility (Sant Prodiksyon Nourimanba in Haitian Creole) was built primarily by Haitian workers, with technical support from more than 50 Abbott engineers, scientists and other experts. Designed to meet international standards for food products, the facility includes modern laboratories and testing technology, with extensive quality and safety procedures. At the same time, the facility was built to be appropriate for Haiti, with rugged equipment that requires little maintenance.

The facility is operated and managed by Haitians, led by PIH's sister organization, Zanmi Lasante ( Partners In Health in Haitian Creole). Abbott and PIH experts provided extensive training for the local team to upgrade manufacturing, production and maintenance skills, and share best practices in quality and food safety. Abbott and PIH also will continue to offer ongoing mentoring and support to ensure long-term sustainable operations.

A Life-Saving Product, Sourced From a Community of FarmersEven prior to the earthquake in January 2010, one in three Haitian children under the age of five suffered from malnutrition. Nourimanba, a ready-to-use therapeutic food product designed to treat severe childhood malnutrition, is a high-calorie, high-protein, fortified paste that is comprised of only five ingredients: peanuts, milk powder, canola oil, sugar and vitamins. Ready to eat by the patient, Nourimanba does not require mixing with water or refrigeration, and can be given to children at home rather than in a hospital, avoiding the cost and complexity of in-patient treatment. Nourimanba produced at the new facility is provided free to any patient in need through a network of clinics supported by PIH/ZL in the Central Plateau and the Artibonite Valley.

The main ingredient in Nourimanba is locally sourced peanuts grown by Haitian farmers. Through the partnership, a pilot program is providing support for approximately 300 farmers to improve the quality and quantity of the peanut supply needed for the facility, while increasing farmer incomes and the overall competitiveness of the local peanut agricultural sector.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs